Detection of JC Virus-Specific Immune Responses in a Novel Humanized Mouse Model

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Tan, Chen Sabrina ^a   Broge, Thomas A ^a   Seung, Edward ^b   Vrbanac, Vlad ^b   Viscidi, Raphael ^c   Gordon, Jennifer ^d,e   Tager, Andrew M ^b   Koralnik, Igor J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRAMMED DEATH 1 RECEPTOR; VIRUS ANTIBODY; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CELL ASSAY; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VIVO STUDY; INOCULATION; JC VIRUS; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE; URINALYSIS; VIRUS CELL INTERACTION; VIRUS IDENTIFICATION; VIRUS INFECTION;

EID: 84877904275     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064313     Document Type: Article

References (27)

1. Tan CS, Koralnik IJ, (2010) Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 9: 425-437.
2. Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, et al. (2009) Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors. J Infect Dis 199 (6):: 837-846.
3. Markowitz RB, Thompson HC, Mueller JF, Cohen JA, Dynan WS, (1993) Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and-uninfected subjects. J Infect Dis 167: 13-20.
4. Du Pasquier RA, Kuroda MJ, Schmitz JE, Zheng Y, Martin K, et al. (2003) Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. J Virol 77: 11918-11926.
5. Du Pasquier RA, Kuroda MJ, Zheng Y, Jean-Jacques J, Letvin NL, et al. (2004) A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 127: 1970-1978.
6. Koralnik IJ, Du Pasquier RA, Kuroda MJ, Schmitz JE, Dang X, et al. (2002) Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol 168: 499-504.
7. Perkins MR, Ryschkewitsch C, Liebner JC, Monaco MC, Himelfarb D, et al. (2012) Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy. PLOS Pathog 8: e1003014.
8. Lima MA, Marzocchetti A, Autissier P, Tompkins T, Chen Y, et al. (2007) Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol 81: 3361-3368.
9. Akkina R, (2013) New generation humanized mice for virus research: comparative aspects and future prospects. Virology 435: 14-28.
10. Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, et al. (2009) Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol 83: 7305-7321.
11. White RE, Ramer PC, Naresh KN, Meixlsperger S, Pinaud L, et al. (2012) EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest 122: 1487-1502.
12. Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, et al. (2006) Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12: 1316-1322.
13. Tan CS, Dezube BJ, Bhargava P, Autissier P, Wuthrich C, et al. (2009) Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J Infect Dis 199: 881-888.
14. Yogo Y, Kitamura T, Sugimoto C, Ueki T, Aso Y, et al. (1990) Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. J Virol 64: 3139-3143.
15. Padgett BL, Walker DL, ZuRhein GM, Hodach AE, Chou SM, (1976) JC Papovavirus in progressive multifocal leukoencephalopathy. J Infect Dis 133: 686-690.
16. Radhakrishnan S, Otte J, Enam S, Del Valle L, Khalili K, et al. (2003) JC virus-induced changes in cellular gene expression in primary human astrocytes. J Virol 77: 10638-10644.
17. Tremolada S, Akan S, Otte J, Khalili K, Ferrante P, et al. (2010) Rare subtypes of BK virus are viable and frequently detected in renal transplant recipients with BK virus-associated nephropathy. Virology 404: 312-318.
18. Ryschkewitsch C, Jensen P, Hou J, Fahle G, Fischer S, et al. (2004) Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluid. J Virol Methods 121: 217-221.
19. Viscidi RP, Khanna N, Tan CS, Li X, Jacobson L, et al. (2011) JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. Clin Infect Dis 53: 711-715.
20. Gheuens S, Bord E, Kesari S, Simpson DM, Gandhi RT, et al. (2011) Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol 85: 7256-7263.
21. Wuthrich C, Dang X, Westmoreland S, McKay J, Maheshwari A, et al. (2009) Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons. Ann Neurol 65: 742-748.
22. Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL, (1999) JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 52: 253-260.
23. Tan CS, Bord E, Broge TA Jr, Glotzbecker B, Mills H, et al. (2012) Increased Program Cell Death- 1 (PD-1) Expression on T Lymphocytes of Patients with Progressive Multifocal Leukoencephalopathy (PML). J Acquir Immune Defic Syndr 60 (3):: 244-248.
24. Smith RW, Nasheuer HP, (2003) Initiation of JC virus DNA replication in vitro by human and mouse DNA polymerase alpha-primase. Eur J Biochem 270: 2030-2037.
25. Gorelik L, Reid C, Testa M, Brickelmaier M, Bossolasco S, et al. (2011) Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity. J Infect Dis 204: 103-114.
26. Reid CE, Li H, Sur G, Carmillo P, Bushnell S, et al. (2011) Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients. J Infect Dis 204: 237-244.
27. Sunyaev SR, Lugovskoy A, Simon K, Gorelik L, (2009) Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML). PLOS Genet 5: e1000368.